• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人细小病毒B19的构建:腺相关病毒2型(AAV)DNA反向末端重复序列在AAV-B19杂交病毒中具有功能。

Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

作者信息

Srivastava C H, Samulski R J, Lu L, Larsen S H, Srivastava A

机构信息

Department of Medicine, Indiana University School of Medicine, Indianapolis 46202.

出版信息

Proc Natl Acad Sci U S A. 1989 Oct;86(20):8078-82. doi: 10.1073/pnas.86.20.8078.

DOI:10.1073/pnas.86.20.8078
PMID:2554300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC298218/
Abstract

To facilitate genetic analysis of the human pathogenic parvovirus B19, we constructed a hybrid B19 viral genome in which the defective B19 inverted terminal repeats were replaced with the full-length inverted terminal repeats from a nonpathogenic human parvovirus, the adeno-associated virus 2 (AAV). The hybrid AAV-B19 genome was rescued from a recombinant plasmid and then the DNA was replicated upon transfection into adenovirus 2-infected human KB cells in the presence of AAV genes coding for proteins required for AAV DNA replication (AAV-Rep proteins). In addition, in the presence of AAV genes coding for the viral capsid proteins (AAV-Cap proteins), the rescued/replicated hybrid AAV-B19 genomes were packed into mature AAV progeny virions, which were subsequently released into culture supernatants. The recombinant AAV-B19 progeny virions were infectious for normal human bone marrow cells and strongly suppressed erythropoiesis in vitro. The availability of an infectious recombinant B19 virus should facilitate the mutational analysis of the viral genome, which, in turn, may yield information on individual viral gene functions in B19-induced pathogenesis. The hybrid AAV-B19 genome may also prove to be a useful vector for gene transfer in human bone marrow cells.

摘要

为便于对人致病性细小病毒B19进行遗传分析,我们构建了一种杂交B19病毒基因组,其中有缺陷的B19反向末端重复序列被来自非致病性人细小病毒——腺相关病毒2(AAV)的全长反向末端重复序列所取代。杂交AAV - B19基因组从重组质粒中拯救出来,然后在编码AAV DNA复制所需蛋白质的AAV基因(AAV - Rep蛋白)存在的情况下,将DNA转染到腺病毒2感染的人KB细胞中进行复制。此外,在编码病毒衣壳蛋白的AAV基因(AAV - Cap蛋白)存在的情况下,拯救/复制的杂交AAV - B19基因组被包装到成熟的AAV子代病毒粒子中,随后释放到培养上清液中。重组AAV - B19子代病毒粒子对正常人骨髓细胞具有感染性,并在体外强烈抑制红细胞生成。有感染性的重组B19病毒的可得性应有助于对病毒基因组进行突变分析,这反过来可能会产生关于B19诱导发病机制中单个病毒基因功能的信息。杂交AAV - B19基因组也可能被证明是一种用于人骨髓细胞基因转移的有用载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/45dafe97b6f2/pnas00287-0429-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/d8fdfcc37698/pnas00287-0428-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/663d9929ec64/pnas00287-0429-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/45dafe97b6f2/pnas00287-0429-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/d8fdfcc37698/pnas00287-0428-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/663d9929ec64/pnas00287-0429-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a3/298218/45dafe97b6f2/pnas00287-0429-b.jpg

相似文献

1
Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.重组人细小病毒B19的构建:腺相关病毒2型(AAV)DNA反向末端重复序列在AAV-B19杂交病毒中具有功能。
Proc Natl Acad Sci U S A. 1989 Oct;86(20):8078-82. doi: 10.1073/pnas.86.20.8078.
2
Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.2型腺相关病毒的拯救与复制以及来自病毒反向末端重复序列存在缺失的重组质粒中的载体DNA序列:病毒基因组在子代病毒颗粒中的选择性包装。
J Virol. 1996 Mar;70(3):1668-77. doi: 10.1128/JVI.70.3.1668-1677.1996.
3
Cloning and integration of DNA fragments in human cells via the inverted terminal repeats of the adeno-associated virus 2 genome.通过腺相关病毒2型基因组的反向末端重复序列实现DNA片段在人类细胞中的克隆与整合。
Gene. 1992 Oct 1;119(2):265-72. doi: 10.1016/0378-1119(92)90281-s.
4
Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes.重组人细小病毒B19载体:红系细胞特异性转导基因的递送与表达
J Virol. 1998 Jun;72(6):5224-30. doi: 10.1128/JVI.72.6.5224-5230.1998.
5
Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.质粒转染和重组腺相关病毒2(AAV)感染后人细小病毒B19 p6启动子在人细胞中的差异表达:人巨核细胞白血病细胞对AAV感染不敏感。
J Gen Virol. 1996 Jun;77 ( Pt 6):1111-22. doi: 10.1099/0022-1317-77-6-1111.
6
A novel terminal resolution-like site in the adeno-associated virus type 2 genome.腺相关病毒2型基因组中一个类似末端分辨率位点的新位点。
J Virol. 1997 Feb;71(2):1140-6. doi: 10.1128/JVI.71.2.1140-1146.1997.
7
Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.位于图谱单位6的细小病毒B19启动子赋予腺相关病毒2在原代人造血祖细胞中的自主复制能力和红系特异性。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12416-20. doi: 10.1073/pnas.92.26.12416.
8
Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro.
Blood. 1990 Nov 15;76(10):1997-2004.
9
In vitro replication of adeno-associated virus DNA.腺相关病毒DNA的体外复制
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4673-7. doi: 10.1073/pnas.89.10.4673.
10
Replication of adeno-associated virus DNA. Complementation of naturally occurring rep- mutants by a wild-type genome or an ori- mutant and correction of terminal palindrome deletions.腺相关病毒DNA的复制。野生型基因组或ori-突变体对天然存在的rep-突变体的互补作用以及末端回文缺失的校正。
J Mol Biol. 1984 Oct 15;179(1):1-20. doi: 10.1016/0022-2836(84)90303-6.

引用本文的文献

1
AAV vector development, back to the future.腺相关病毒载体的发展,回归未来。
Mol Ther. 2025 May 7;33(5):1903-1936. doi: 10.1016/j.ymthe.2025.03.064. Epub 2025 Apr 3.
2
Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.最佳可能世界:基于细小病毒和异源病毒的混合基因治疗载体。
Mol Ther. 2021 Dec 1;29(12):3359-3382. doi: 10.1016/j.ymthe.2021.04.005. Epub 2021 Apr 5.
3
Adeno-Associated Virus and Hematopoietic Stem Cells: The Potential of Adeno-Associated Virus Hematopoietic Stem Cells in Genetic Medicines.

本文引用的文献

1
Conformation takes precedence over sequence in adeno-associated virus DNA replication.在腺相关病毒DNA复制中,构象比序列更重要。
Mol Cell Biol. 1984 Jul;4(7):1416-9. doi: 10.1128/mcb.4.7.1416-1419.1984.
2
Cloning of infectious adeno-associated virus genomes in bacterial plasmids.在细菌质粒中克隆感染性腺相关病毒基因组。
Gene. 1983 Jul;23(1):65-73. doi: 10.1016/0378-1119(83)90217-2.
3
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.一种将DNA限制性内切酶片段放射性标记至高比活度的技术。
腺相关病毒与造血干细胞:腺相关病毒造血干细胞在基因药物中的潜力。
Hum Gene Ther. 2020 May;31(9-10):542-552. doi: 10.1089/hum.2020.049.
4
Engineering adeno-associated virus vectors for gene therapy.工程腺相关病毒载体用于基因治疗。
Nat Rev Genet. 2020 Apr;21(4):255-272. doi: 10.1038/s41576-019-0205-4. Epub 2020 Feb 10.
5
Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses.基于腺相关病毒和四种不同哺乳动物博卡病毒的新型嵌合基因治疗载体
Mol Ther Methods Clin Dev. 2019 Jan 18;12:202-222. doi: 10.1016/j.omtm.2019.01.003. eCollection 2019 Mar 15.
6
Virus-based gene delivery systems.基于病毒的基因递送系统。
Clin Pharmacokinet. 2002;41(12):901-11. doi: 10.2165/00003088-200241120-00001.
7
Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes.重组人细小病毒B19载体:红系细胞特异性转导基因的递送与表达
J Virol. 1998 Jun;72(6):5224-30. doi: 10.1128/JVI.72.6.5224-5230.1998.
8
Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin.通过单次肌肉注射编码小鼠瘦素的重组腺相关病毒对遗传性肥胖小鼠的肥胖和糖尿病进行长期矫正。
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13921-6. doi: 10.1073/pnas.94.25.13921.
9
Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D.用表达单纯疱疹病毒2型糖蛋白B和D的腺相关病毒载体进行基因免疫。
J Virol. 1997 Oct;71(10):7960-2. doi: 10.1128/JVI.71.10.7960-7962.1997.
10
Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.野生型和重组子代病毒粒子中2型腺相关病毒Rep蛋白的衣壳化:Rep介导的原代人类细胞生长抑制
J Virol. 1997 Oct;71(10):7361-71. doi: 10.1128/JVI.71.10.7361-7371.1997.
Anal Biochem. 1983 Jul 1;132(1):6-13. doi: 10.1016/0003-2697(83)90418-9.
4
Nucleotide sequence and organization of the adeno-associated virus 2 genome.腺相关病毒2型基因组的核苷酸序列与结构
J Virol. 1983 Feb;45(2):555-64. doi: 10.1128/JVI.45.2.555-564.1983.
5
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.将腺相关病毒克隆至pBR322:在人细胞中从重组质粒拯救完整病毒。
Proc Natl Acad Sci U S A. 1982 Mar;79(6):2077-81. doi: 10.1073/pnas.79.6.2077.
6
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication.1型和2型单纯疱疹病毒完全有助于腺病毒相关病毒的复制。
J Virol. 1981 Oct;40(1):241-7. doi: 10.1128/JVI.40.1.241-247.1981.
7
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA.腺相关病毒DNA中反向末端重复序列的核苷酸序列。
J Virol. 1980 May;34(2):402-9. doi: 10.1128/JVI.34.2.402-409.1980.
8
Intrauterine parvovirus infection associated with hydrops fetalis.与胎儿水肿相关的宫内细小病毒感染。
Lancet. 1984 Nov 3;2(8410):1033-4. doi: 10.1016/s0140-6736(84)91126-7.
9
Human parvovirus, the cause of erythema infectiosum (fifth disease)?人类细小病毒,是传染性红斑(第五病)的病因吗?
Lancet. 1983 Jun 18;1(8338):1378. doi: 10.1016/s0140-6736(83)92152-9.
10
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent.与细小病毒样病原体相关的镰状细胞贫血再生障碍危象暴发。
Lancet. 1981 Sep 19;2(8247):595-7. doi: 10.1016/s0140-6736(81)92739-2.